Inaction by US pharmaceutical corporation Gilead to follow through on its so-called ‘access initiative’ leaves people unable to access a vital drug to treat a deadly infection
With years of experience campaigning for access to essential medicines in South African, MSF fieldworker Claire Waterhouse, found herself working as the coordinator in a project treating hepatitis C in Meerut, India.
MSF is supporting a patent challenge filed in India this week by two DR-TB survivors, to prevent pharmaceutical corporation J&J from extending its monopoly on the TB drug bedaquiline
MSF calls on countries with large numbers of people with DR-TB to urgently start implementing these new treatment guidelines
In Jharkhand, an Indian state known for its diverse tribal communities, the number of people that are malnourished is persistently higher than the national average.
In January 2017, MSF, in collaboration with the National Health Mission in Uttar Pradesh, started a pilot hepatitis project in Meerut city.
At High Court of Delhi hearing tomorrow, MSF will urge India to remain the “pharmacy of the developing world” and rethink decision that solidifies Pfizer monopoly on critical pneumonia vaccine
Hopes for improved access to an affordable pneumococcal conjugate vaccine (PCV) that safeguards both children and adults from pneumonia was dealt a major blo
The Medicines Patent Pool has signed a licence with Johns Hopkins University to facilitate the clinical development of TB drug candidate sutezolid.